<h4>Background</h4><i>SCN4A</i> mutations account for a diverse array of clinical manifestations, encompassing periodic paralysis, myotonia, and newly recognized symptoms like classical congenital myopathy or congenital myasthenic syndromes. This evidence concerns the gene SCN4A and Congenital myasthenic syndromes.